NowVille
______
Update: Friday Feb 26th...A direct assessment of asymptomatic subject strongly suggests one dose of the Pfizer mRNA vaccine strongly suppresses viral transmission...Details here.
______
This being Sunday and all, you may have not yet seen or heard the big 'news' from Israel.
Which is that the Pfizer mRNA vaccine is, apparently, according to news reports, ~90% effective at preventing SARS-CoV-2 infections.
Why is this a big deal and something you're almost surely very likely to hear about by the end of the news cycle (i.e. by tomorrow morning)?
Because we're talking about stopping viral spread here, in addition to preventing or curtailing serious illness after viral infection.
One of the first reports (although there are others) of this 'finding' is from Naomi Kresge and Jason Gale at Bloomberg.
Here is their lede:
The Pfizer Inc. and BioNTech SE Covid-19 vaccine appeared to stop the vast majority of recipients in Israel becoming infected, providing the first real-world indication that the immunization will curb transmission of the coronavirus.
The vaccine, which was rolled out in a national immunization program that began Dec. 20, was 89.4% effective at preventing laboratory-confirmed infections, according to a copy of a draft publication that was posted on Twitter and confirmed by a person familiar with the work. The companies and Israel’s Health Ministry worked together on the preliminary observational analysis, which has not yet been peer-reviewed...
Now, that last bit about how the 'draft publication' has not been peer reviewed is a red flag, especially given that reporters Kresge and Gale do not appear to have, based on what is in their report at least, spoken to a field-specific expert who has read the draft publication carefully and made a call one way or the other about whether the conclusions made are supported by the data presented (which is, essentially, what peer reviewers do).
The Pfizer Inc. and BioNTech SE Covid-19 vaccine appeared to stop the vast majority of recipients in Israel becoming infected, providing the first real-world indication that the immunization will curb transmission of the coronavirus.
The vaccine, which was rolled out in a national immunization program that began Dec. 20, was 89.4% effective at preventing laboratory-confirmed infections, according to a copy of a draft publication that was posted on Twitter and confirmed by a person familiar with the work. The companies and Israel’s Health Ministry worked together on the preliminary observational analysis, which has not yet been peer-reviewed...
Now, that last bit about how the 'draft publication' has not been peer reviewed is a red flag, especially given that reporters Kresge and Gale do not appear to have, based on what is in their report at least, spoken to a field-specific expert who has read the draft publication carefully and made a call one way or the other about whether the conclusions made are supported by the data presented (which is, essentially, what peer reviewers do).
Luckily Eric Topol, the guy from Scripps who helped demonstrate how prevalent asympomatic viral infections are, has identified such an expert who has read the draft carefully.
To put it mildly that expert, who is a faculty member at the University of Maryland School of Public Policy, is concerned that the conclusions made, which are now being trumpeted loudly in the public prints, are an overstatement:
****
So.
Well, she is concerned with the fact that testing rates differ between vaccinated and unvaccinated people in Israel. As such, she is further concerned that the 'observed' differences in infections between the two groups are not the same as the 'actual' differences. Importantly, the authors of the 'draft publication'/pre-print itself also note this problem:
Thus, the issue that Dr. McLaren has with the draft and, especially the media trumpets, is not whether or not the vaccine helps prevent viral spread but instead what the actual efficacy number is.
Thus, the issue that Dr. McLaren has with the draft and, especially the media trumpets, is not whether or not the vaccine helps prevent viral spread but instead what the actual efficacy number is.
OK?
_______
This thing gets even more bizarre in that the 'draft publication' is not sitting on a pre-print server for all to see as is the usual way that authors try to get comment/feedback prior to publication...Instead, it was 'leaked' to Israeli journalist Edav Eyal who then posted it, via screenshot, on the Twittmachine.
.
6 comments:
Not settled by any measure, but the reports are trending in a positive direction at the moment.
Here's another:
https://www.theguardian.com/world/2021/feb/22/scotland-covid-vaccination-drive-linked-to-big-drop-in-hospital-admissions
News by news release, nothing new here, as it is how the media treat news releases by TransLink.
The media does so little fact checking these days and almost any absurdity gets printed.
Anon-At-The-Top--
Fair enough.
There is definitely strong vaccine-mediate protection against symptoms and disease progression as is detailed in your link to today's piece in the Guardian. This is all holding up as per the clinical trials. One note of caution there though is the South African (B.1.351) variant.
Here, however, we're talking about preventing viral spread by vaccine-mediate blocking of infection. The argument of folks looking closely at what has been 'leaked' is not that there isn't a positive effect on preventing spread but rather that, based on the methods and data presented, that the authors are likely overstating the effect.
.
E.E.--
It's actually science/healthcare news by 'leak' which is even sneakier. At least with a 'release' you know where the stuff is actually coming from.
.
There is a new article up at the ‘ol Tyee that is by an Australian doctor who was on the trip to China with the WHO contingent to try and figure out the origins of Covid 19. It’s a quick review of his time there and what they did, a report will be released in due course. You may find it interesting.
Thanks for the updates and info you find, I have been passing them on to folks that are looking for a little more than what is in the locals.
Thanks Graham--
Don't forget I am not a scientific expert on the topic.
Two folks well worth following on the Twittmachine on that front, if you are into that, are:
Eric Topol and Derek Lowe.
.
Post a Comment